- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
TNF Pharmaceuticals Inc (TNFA)
TNF Pharmaceuticals Inc stock price live, this page displays NASDAQ TNFA stock exchange data. View the TNFA premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the TNF Pharmaceuticals Inc real time stock price chart below.
What Is the TNF Pharmaceuticals Inc Stock Price Today?
The TNF Pharmaceuticals Inc stock price today is 0.117.
What Is the Stock Symbol for TNF Pharmaceuticals Inc?
The stock symbol for TNF Pharmaceuticals Inc is ""TNFA.""
What Stock Exchange Does TNF Pharmaceuticals Inc Trade On?
TNF Pharmaceuticals Inc is listed and trades on the NASDAQ stock exchange.
Is TNF Pharmaceuticals Inc a Good Stock to Buy?
Determining whether TNF Pharmaceuticals Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the TNFA quote. (ISIN: US62856X2018)
What Is the TNF Pharmaceuticals Inc Stock Price Today?
The TNF Pharmaceuticals Inc stock price today is 0.117.
What Is the Stock Symbol for TNF Pharmaceuticals Inc?
The stock symbol for TNF Pharmaceuticals Inc is ""TNFA.""
What Stock Exchange Does TNF Pharmaceuticals Inc Trade On?
TNF Pharmaceuticals Inc is listed and trades on the NASDAQ stock exchange.
Is TNF Pharmaceuticals Inc a Good Stock to Buy?
Determining whether TNF Pharmaceuticals Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the TNFA quote. (ISIN: US62856X2018)
0.117
-0.015(-11.36%)
Closed·
After Hours
0.114-0.003(-2.31%)
·
Fair Value
An estimate of a TNF Pharmaceuticals's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.110
0.129
52 wk Range
0.085
2.160
TNFA Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Unusual trading volume
Fair Value
An estimate of a TNF Pharmaceuticals's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.1100.129
52 wk Range
0.0852.160
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
TNFA Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a TNF Pharmaceuticals's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Neutral
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Stock has taken a big hit over the last week
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Neutral
Moving Averages
Sell
TNF Pharmaceuticals Inc Company Profile
TNF Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, focuses on developing and commercializing therapeutic platforms based on various therapeutic targets. The company develops Isomyosamine, a clinical stage small molecule that regulates the immunometabolic system to treat autoimmune disease, including sarcopenia, frailty, adverse effects of drugs used to treat diabetes and obesity, rheumatoid arthritis, and inflammatory bowel disease. It also develops Supera-CBD, a synthetic analog of derivative of cannabidiol (CBD) to treat various conditions, including epilepsy, pain and anxiety/depression. The company has a strategic alliance with DADA2 Foundation for research into the rare inflammatory disease DADA2 (Deficiency of Adenosine Deaminase 2). TNF Pharmaceuticals, Inc. was formerly known as MyMD Pharmaceuticals, Inc. and changed its name to TNF Pharmaceuticals, Inc. in July 2024. The company was founded in 2014 and is headquartered in New York, New York.
Compare TNFA to Peers and Sector
Metrics to compare | TNFA | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipTNFAPeersSector | |
|---|---|---|---|---|
P/E Ratio | −0.1x | −1.5x | −0.5x | |
PEG Ratio | 0.00 | −0.01 | 0.00 | |
Price/Book | 0.2x | 1.2x | 2.6x | |
Price / LTM Sales | - | 2.2x | 3.2x | |
Upside (Analyst Target) | - | 122.1% | 41.6% | |
Fair Value Upside | Unlock | 20.8% | 6.0% | Unlock |
Earnings
Latest Release
May 15, 2025
EPS / Forecast
-0.36 / --
Revenue / Forecast
-- / --
People Also Watch
FAQ
What Stock Exchange Does TNF Pharmaceuticals Trade On?
TNF Pharmaceuticals is listed and trades on the Nasdaq Stock Exchange stock exchange.
What Is the Stock Symbol for TNF Pharmaceuticals?
The stock symbol for TNF Pharmaceuticals is "TNFA."
What Is the TNF Pharmaceuticals Market Cap?
As of today, TNF Pharmaceuticals market cap is 1.66M.
What Is TNF Pharmaceuticals's Earnings Per Share (TTM)?
The TNF Pharmaceuticals EPS (TTM) is -5.59.
From a Technical Analysis Perspective, Is TNFA a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.
How Many Times Has TNF Pharmaceuticals Stock Split?
TNF Pharmaceuticals has split 4 times.
How Many Employees Does TNF Pharmaceuticals Have?
TNF Pharmaceuticals has 2 employees.
What is the current trading status of TNF Pharmaceuticals (TNFA)?
As of 28 Jul 2025, TNF Pharmaceuticals (TNFA) is trading at a price of 0.12, with a previous close of 0.13. The stock has fluctuated within a day range of 0.11 to 0.13, while its 52-week range spans from 0.09 to 2.16.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.